360 related articles for article (PubMed ID: 29084737)
1. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Dellborg M; Bonaca MP; Storey RF; Steg PG; Im KA; Cohen M; Bhatt DL; Oude Ophuis T; Budaj A; Hamm C; Spinar J; Kiss RG; Lopez-Sendon J; Kamensky G; Van de Werf F; Ardissino D; Kontny F; Montalescot G; Johanson P; Bengtsson O; Himmelmann A; Braunwald E; Sabatine MS
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):200-206. PubMed ID: 31218354
[TBL] [Abstract][Full Text] [Related]
4. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Magnani G; Ardissino D; Im K; Budaj A; Storey RF; Steg PG; Bhatt DL; Cohen M; Oude Ophius T; Goudev A; Parkhomenko A; Kamensky G; Angiolillo DJ; López-Sendón J; Johanson P; Braunwald E; Sabatine MS; Bonaca MP
J Am Heart Assoc; 2021 Feb; 10(4):e017008. PubMed ID: 33559485
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
6. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
7. Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.
Bhatt DL; Bonaca MP; Bansilal S; Angiolillo DJ; Cohen M; Storey RF; Im K; Murphy SA; Held P; Braunwald E; Sabatine MS; Steg PG
J Am Coll Cardiol; 2016 Jun; 67(23):2732-2740. PubMed ID: 27046160
[TBL] [Abstract][Full Text] [Related]
8. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA
Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Jensen EC; Magnani G; Bansilal S; Fish MP; Im K; Bengtsson O; Oude Ophuis T; Budaj A; Theroux P; Ruda M; Hamm C; Goto S; Spinar J; Nicolau JC; Kiss RG; Murphy SA; Wiviott SD; Held P; Braunwald E; Sabatine MS;
N Engl J Med; 2015 May; 372(19):1791-800. PubMed ID: 25773268
[TBL] [Abstract][Full Text] [Related]
10. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
[TBL] [Abstract][Full Text] [Related]
11. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
[TBL] [Abstract][Full Text] [Related]
12. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial.
Bonaca MP; Bhatt DL; Braunwald E; Cohen M; Steg PG; Storey RF; Held P; Jensen EC; Sabatine MS
Am Heart J; 2014 Apr; 167(4):437-444.e5. PubMed ID: 24655690
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease.
Bansilal S; Bonaca MP; Cornel JH; Storey RF; Bhatt DL; Steg PG; Im K; Murphy SA; Angiolillo DJ; Kiss RG; Parkhomenko AN; Lopez-Sendon J; Isaza D; Goudev A; Kontny F; Held P; Jensen EC; Braunwald E; Sabatine MS; Oude Ophuis AJ
J Am Coll Cardiol; 2018 Feb; 71(5):489-496. PubMed ID: 29406853
[TBL] [Abstract][Full Text] [Related]
15. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Furtado RHM; Venkateswaran RV; Nicolau JC; Gurmu Y; Bhatt DL; Storey RF; Steg PG; Magnani G; Goto S; Dellborg M; Kamensky G; Isaza D; Aylward P; Johanson P; Bonaca MP
J Am Heart Assoc; 2020 May; 9(10):e015785. PubMed ID: 32410485
[TBL] [Abstract][Full Text] [Related]
16. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
Cavender MA; Scirica BM; Bonaca MP; Angiolillo DJ; Dalby AJ; Dellborg M; Morais J; Murphy SA; Ophuis TO; Tendera M; Braunwald E; Morrow DA
Circulation; 2015 Mar; 131(12):1047-53. PubMed ID: 25681464
[TBL] [Abstract][Full Text] [Related]
17. The Acute S
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.
Magnuson EA; Li H; Wang K; Vilain K; Shafiq A; Bonaca MP; Bhatt DL; Cohen M; Steg PG; Storey RF; Braunwald E; Sabatine MS; Cohen DJ;
J Am Coll Cardiol; 2017 Aug; 70(5):527-538. PubMed ID: 28750695
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
Bonaca MP; Wiviott SD; Morrow DA; Steg PG; Hamm C; Bhatt DL; Storey RF; Cohen M; Kuder J; Im K; Magnani G; Budaj A; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Diaz R; Van de Werf F; Corbalán R; Goudev A; Jensen EC; Johanson P; Braunwald E; Sabatine MS
J Am Heart Assoc; 2018 Nov; 7(22):e009260. PubMed ID: 30571502
[TBL] [Abstract][Full Text] [Related]
20. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Furtado RHM; Nicolau JC; Magnani G; Im K; Bhatt DL; Storey RF; Steg PG; Spinar J; Budaj A; Kontny F; Corbalan R; Kiss RG; Abola MT; Johanson P; Jensen EC; Braunwald E; Sabatine MS; Bonaca MP
Eur Heart J; 2020 May; 41(17):1625-1632. PubMed ID: 31811715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
